Mizuho Forecasts Strong Price Appreciation for Corteva (NYSE:CTVA) Stock

Corteva (NYSE:CTVA) had its price objective upped by stock analysts at Mizuho from $82.00 to $94.00 in a report released on Wednesday,MarketScreener reports. The firm presently has an “outperform” rating on the stock. Mizuho’s price target would indicate a potential upside of 15.87% from the company’s current price.

A number of other brokerages have also weighed in on CTVA. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Corteva in a research note on Monday, December 29th. BNP Paribas Exane upped their target price on shares of Corteva from $72.00 to $74.00 in a research note on Monday, March 9th. Wall Street Zen lowered shares of Corteva from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Berenberg Bank upped their target price on shares of Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research note on Thursday, March 26th. Finally, The Goldman Sachs Group upped their target price on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research note on Tuesday. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $84.52.

Corteva Price Performance

Shares of CTVA stock opened at $81.12 on Wednesday. Corteva has a 12-month low of $58.58 and a 12-month high of $85.63. The firm has a market capitalization of $54.46 billion, a price-to-earnings ratio of 51.34, a price-to-earnings-growth ratio of 2.78 and a beta of 0.68. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The firm has a fifty day moving average of $79.40 and a 200-day moving average of $70.96.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the previous year, the business earned $0.32 EPS. The firm’s revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts forecast that Corteva will post 2.96 earnings per share for the current year.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of the stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.15% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Corteva

Large investors have recently modified their holdings of the business. Activest Wealth Management boosted its stake in shares of Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after buying an additional 200 shares during the last quarter. JPL Wealth Management LLC acquired a new position in shares of Corteva during the 3rd quarter worth about $25,000. True Wealth Design LLC boosted its stake in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after buying an additional 264 shares during the last quarter. Garton & Associates Financial Advisors LLC acquired a new position in shares of Corteva during the 4th quarter worth about $27,000. Finally, Bank of Jackson Hole Trust acquired a new position in shares of Corteva during the 4th quarter worth about $28,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.